Newsroom
Sorted by: Latest
-
Grid Dynamics Co-Hosts Physical AI Summit Alongside NVIDIA, EAIGG, and BGV to Accelerate Manufacturing Automation
SAN RAMON, Calif.--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a premier AI transformation partner for the Fortune 1000, announced today that it is co-hosting the Physical AI Summit alongside NVIDIA, EAIGG, and BGV. The invite-only working forum will bring together participants from enterprises, Physical AI startups, and investors on September 24, 2026, at the Wells Fargo Innovation Center in Menlo Park, CA. Centered on the theme "From World Models to Real-Wo...
-
Celyad Oncology publie ses résultats financiers du premier semestre 2026
MONT-SAINT-GUIBERT, Belgique--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Euronext: CYAD) (« Celyad » ou la « Société ») a annoncé aujourd'hui ses résultats financiers pour le premier semestre 2026 clos au 30 juin 2026. Bilan financier du premier semestre 2026 Au 30 juin 2026, la trésorerie de la Société s'élevait à 0,1 M€. Il convient de noter l'événement survenu après la date de clôture (30 juin), à savoir l'augmentation de capital de 0,5 million d'euros réalisée le 16 juillet 2026, qu...
-
Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (NYSE: EVMN) (“Evommune” or the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that data from the Phase 2a trial of EVO301 in moderate-to-severe atopic dermatitis (AD) will be presented in a late-breaking oral session at the upcoming European Academy of Dermatology & Venereology (EADV) Congress, taking place in Vienna, Au...
-
Virtus Diversified Income & Convertible Fund Announces Increase to Monthly Distributions and Discloses Sources of Distribution – Section 19(a) Notice
HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Diversified Income & Convertible Fund (NYSE: ACV) today announced it will increase its monthly distribution from $0.18 per share to $0.215 per share, an increase of 19% or $0.035 per share, effective with the October distribution: Ticker Amount of Distribution Ex-Date/Record Date Payable Date ACV $0.215 October 13, 2026 October 29, 2026 ACV $0.215 November 12, 2026 November 27, 2026 This increase is part of the Fund’s ongoing efforts to enhance share...
-
Celyad Oncology Reports First Half Year 2026 Results
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Euronext: CYAD) (“Celyad” or the “Company”), today announced its financial results for the first half year 2026 ended June 30, 2026. First Half 2026 financial review As of June 30, 2026, the Company’s cash position amounted to €0.1 million. Noteworthy is the event post balance sheet date (June 30), namely the capital increase with €0.5 million dated July 16, 2026 which has strengthened the cash position. After due c...
-
H.B. Fuller Reports Third Quarter 2026 Results
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today reported financial results for its third quarter that ended August 29, 2026. Third Quarter 2026 Noteworthy Items: Net revenue was $938 million, up 5.2% year-on-year; organic revenue was up 4.4% year-on-year, with organic revenue growth in all three global business units; Gross margin was 33.2%; adjusted gross margin of 33.5% increased 120 basis points year-on-year driven mainly by pricing execution and restructuring savings...
-
Evofem Biosciences Adds Additional Manufacturing Capacity for PHEXX® to Support Global Growth Strategy
SAN DIEGO--(BUSINESS WIRE)--Women’s health innovator Evofem Biosciences, Inc. (OTCID: EVFM) has achieved an important milestone in its strategy to support long-term growth, enhance manufacturing flexibility, and reduce costs. Evofem has contracted with a second pharmaceutical manufacturer to produce PHEXX® (lactic acid, citric acid and potassium bitartrate), its hormone-free, on-demand prescription contraceptive vaginal gel. Subject to regulatory approval, the additional manufacturing source is...
-
Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced its financial results for the fourth quarter and full fiscal year 2026 ended August 1, 2026. “Fiscal 2026 was a transformative year for Stitch Fix. We closed the year as a significantly healthier business, with a strengthened operating foundation, along with a reimagined client experience and more compelling assortment,” said Matt Baer, CEO, Stitch Fix. “Full-year revenu...
-
Royal Gold Presenting at the John Tumazos Very Independent Research 2026 Virtual Conference
DENVER--(BUSINESS WIRE)--Royal Gold Presenting at the John Tumazos Very Independent Research 2026 Virtual Conference...
-
Planet Announces Amazon.ia – A New Tool That Combines Satellite Data, Science and AI to Protect the Amazon
SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced the launch of Amazon.ia - Inteligencia Ambiental, an ambitious multi-partner initiative dedicated to producing timely, actionable intelligence on biodiversity to drive effective conservation and restoration across the Amazon. The initiative is supported by many partners, including Planet and the Bezos Earth Fund, which granted more than $14M across both...